NASDAQ$BLFS

BioLife Solutions Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

BioLife Solutions experienced significant revenue growth and addressed operational challenges.

BioLife Solutions reported a 200% increase in total revenue for Q3 2021 compared to Q3 2020, with organic revenue growth of 37%. The company is addressing operational issues related to Stirling ULT freezers to improve gross margins.

  • Total revenue increased by 200% compared to Q3 2020.
  • Organic revenue grew by 37% year-over-year.
  • Completed the acquisition of Sexton Biotechnologies.
  • Updated 2021 revenue guidance to $115 million to $119 million.

Headline financials

Total Revenue

$33.8M

Previous: $11.3M+199.7%
EPS (adj)

-$0.19

Previous: -$0.02-850.0%
GAAP gross margin

25.0%

Previous: 52.0%-51.9%
Non-GAAP adjusted gross margin

28.0%

Previous: 57.0%-50.9%
GAAP operating loss

-$11.2M

Previous: -$1.2M-833.3%
Adjusted EBITDA

-$2.1M

Previous: $1.7M-223.5%
Capital Expenditures

-$6.82M

Previous: -$370K-1743.0%
Free Cash Flow

-$6.74M

Previous: -$1.5M-348.4%
Net Income

$79K

Previous: -$1.13M+107.0%
Operating Income

-$11.2M

Previous: -$1.25M-795.6%
Gross Profit

$8.45M

Previous: $6.45M+30.9%
Cash & Equivalents

$75.1M

Previous: $109M-31.1%
Total Assets

$559M

Previous: $196M+185.6%

Revenue & EPS history

BioLife · Revenue · Quarterly

$33.8M

Q3 2021+199.7%vs Q3 2020
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

BioLife · $11.5M total across 1 segment · Q3 2021

  • Cell Processing platform
    $11.5M+55.4%

Forward guidance

BioLife updated its 2021 revenue guidance to a range of $115 million to $119 million, reflecting a year-over-year growth of 139% to 147%.

Tailwinds

  • Cell processing platform revenue is expected to be $42 million to $43 million, an increase of 36% to 39% over the prior year.
  • Freezers and Thaw Systems platform revenue is expected to be $57 million to $59 million, an increase of 321% to 335% over the prior year.
  • Storage and Cold Chain Services platform revenue is expected to be $16 million to $17 million, an increase of 345% to 373% over the prior year.
  • Strong demand for proprietary biopreservation media products.
  • Focus on reducing cost variances and warranty expense.

Headwinds

  • No specific negatives were mentioned in the provided text.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+4.3%

Avg return

30 days after

44%

22 / 50 earnings

Positive

+21.4%

Q3 2022

Best reaction

-34.5%

Q4 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.3%-2.4%+22.4%
Q4 2025+8.0%-8.1%-17.3%
Q3 2025-4.2%-4.1%-5.8%
Q2 2025+10.0%+24.4%+28.2%
Q1 2025+4.0%-1.4%+6.0%
Q4 2024+2.1%+7.6%-0.9%
Q3 2024-9.4%-21.0%+0.5%
Q2 2024+14.5%+20.3%+7.9%
Q1 2024+8.9%+25.0%+13.2%
Q4 2023+5.1%-0.5%+8.5%
Q3 2023-5.7%+3.1%+14.2%
Q2 2023-29.7%-34.9%-30.3%
Q1 2023-2.9%+3.5%+20.6%
Q4 2022+0.2%+2.7%-7.4%
Q3 2022+21.4%+14.1%-4.6%
Q2 2022+13.7%+15.7%+25.6%
Q1 2022-3.8%+1.6%+18.3%
Q4 2021-0.3%+0.9%-3.7%
Q3 2021-6.0%+5.2%-30.3%
Q2 2021-1.8%-3.9%+12.0%
Q1 2021-2.1%+4.8%+25.1%
Q4 2020+8.3%-7.8%-14.7%
Q3 2020+5.8%+0.8%+21.6%
Q2 2020+0.3%-5.4%+5.6%
Q1 2020+3.0%+10.5%+1.5%
Q4 2019-34.5%-36.7%-27.8%
Q3 2019-12.8%-8.8%-7.4%
Q2 2019-6.2%+1.1%+7.7%
Q1 2019-2.4%+4.5%+8.8%
Q4 2018+10.7%+19.4%+5.5%
Q3 2018+15.0%-8.0%-7.8%
Q2 2018-4.8%-1.0%+2.3%
Q1 2018-3.7%+7.6%+23.5%
Q4 2017-4.4%-10.2%+22.4%
Q3 2017+18.0%+21.6%+8.2%
Q2 2017+3.8%+8.2%+30.6%
Q1 2017+3.7%-1.4%+7.8%
Q4 2016-5.0%-9.5%-7.7%
Q3 2016+0.7%+2.7%+5.4%
Q2 2016-2.4%-7.7%-15.9%
Q3 2012+10.0%
Q1 2012+0.0%
Q4 2011+0.0%
Q3 2011+0.0%
Q2 2011-14.3%
Q1 2011+0.0%
Q4 2010-11.1%
Q3 2010+0.0%
Q2 2010+0.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro